Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMVT96Q)

Drug Name
BBP-711 Drug Info
Indication
Disease Entry ICD 11 Status REF
Primary hyperoxaluria type 1 5C51.20 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMVT96Q

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
2-Hydroxyacid oxidase 1 (HAO1) TT0A11O HAOX1_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT04876924) A Phase 1, Randomized, Double-Blinded, Placebo-controlled, Single and Multiple-Ascending Dose Study of the Safety, Tolerability, Food Effect, Pharmacokinetics, and Pharmacodynamics of BBP-711 (ORF-229) in Healthy Adult Subjects. U.S.National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight